Greenberg v. Miami Children's Hospital Research Institute
{{Short description|Florida court case}}
{{Use mdy dates|date=September 2023}}
{{Infobox United States District Court case
| name = Greenberg v. Miami Children's Hospital Research Institute
| court = United States District Court for the Southern District of Florida
| image = 100px
| imagesize = 150
| caption =
| full name = Daniel Greenberg, Fern Kupfer, Frieda Eisen, David Green, Canavan Foundation, Dor Yeshorim, and National Tay-Sachs and Allied Diseases Association, Inc. v. Miami Children's Hospital Research Institute, Inc., Variety Children's Hospital, Inc. d/b/a Miami Children's Hospital, and Reuben Matalon
| date decided = May 29, 2003
| citations = 264 F. Supp. 2d [https://www.leagle.com/decision/20031328264fsupp2d106411222 1064]
| docket = 02-cv-22244
| transcripts =
| judge = Federico A. Moreno
| prosecutor =
| counsel for plaintiff =
| plaintiff =
| defendant =
| prior actions =
| subsequent actions =
| holding =
| keywords =
}}
Greenberg v. Miami Children's Hospital Research Institute, 264 F. Supp. 2d 1064 (S.D. Fla. 2003), was a decision by the United States District Court for the Southern District of Florida which ruled that individuals do not own their tissue samples when researchers take them for testing.
History
The plaintiffs in this case were a group of parents of children who had Canavan disease and three non-profit organizations who developed a confidential Canavan disease registry and database.{{Cite journal| last1 = United States District Court | first1 = S. D. F. | title = Greenberg v. Miami Children's Hospital Research Institute | journal = West's Federal Supplement | volume = 264 | pages = 1064–1078 | year = 2003 | pmid = 15776537}} The parents provided their children's tissue for research on the disease and the non-profit groups aided in the identification of other affected families. The defendant was Reuben Matalon, who received these tissue samples and used them to isolate and patent the Canavan gene sequence. He subsequently developed a genetic screening test for it and began claiming royalties whenever the test was used. The Miami facilities where he did his research, including Miami Children's Hospital, were also defendants.
Decision
The court dismissed the plaintiffs' claims that the defendants did not provide informed consent, conducted a breach of fiduciary duties, concealed the patent, and misappropriated trade secrets. The court did uphold the plaintiffs' claim of unjust enrichment at the expense of the donors of tissue, writing that "the facts paint a picture of a continuing research collaboration that involved plaintiffs also investing time and significant resources."
Significance
The case set a precedent for determining ownership of donated tissue samples.{{cite web |url=http://www.ipfrontline.com/depts/article.aspx?id=12910&deptid=5 |title=Patent Rights in Biological Material |first=Paula C. |last=Evans |work=ipfrontline.com |date=3 October 2006 |access-date=25 November 2011 |archive-url=https://archive.today/20120907234846/http://www.ipfrontline.com/depts/article.aspx?id=12910&deptid=5 |archive-date=7 September 2012 |url-status=dead }}{{cite web |url= http://www.dddmag.com/intellectual-property-and-biological-materials.aspx |title=Who Owns My Tissue? |first1=J. Mark |last1= Waxman |work=dddmag.com |date=1 December 2007 |access-date=25 November 2011}}
References
{{reflist}}
External links
- {{caselaw source
| case = Greenberg v. Miami Children's Hospital Research Institute, 264 F. Supp. 2d 1064 (S.D. Fla. 2003)
| courtlistener =https://www.courtlistener.com/opinion/2507167/greenberg-v-miami-childrens-hospital-res-inst-inc/
| googlescholar = https://scholar.google.com/scholar_case?case=15803440069702275727
| leagle =https://www.leagle.com/decision/20031328264fsupp2d106411222
}}
- [http://www.canavanfoundation.org/news/09-03_miami.php Canavan Foundation's press release]
{{Medical ethics cases}}
Category:2003 in United States case law
Category:United States District Court for the Southern District of Florida cases